Results 151 to 160 of about 642,659 (199)

From Disease Silos to Integrated Cardiometabolic Care: Diabetes, Vascular Disease, and Heart Failure

open access: yes
Journal of Diabetes, Volume 18, Issue 9, September 2026.
Zachary T. Bloomgarden   +1 more
wiley   +1 more source

Real-world effectiveness and cardiovascular outcomes of PCSK9 inhibitor therapy: a prospective registry study. [PDF]

open access: yesLipids Health Dis
Kafol J   +12 more
europepmc   +1 more source

Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor. [PDF]

open access: yesJ Adv Res
Xu R   +17 more
europepmc   +1 more source

Potential bias in observational PCSK9 inhibitor study. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Blais JE, Wong AYS.
europepmc   +1 more source

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor on Immune-Inflammatory Responses in the Acute Phase of Ischemic Stroke. [PDF]

open access: yesJ Inflamm Res
Li Z   +14 more
europepmc   +1 more source

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation. [PDF]

open access: yesJ Am Heart Assoc, 2023
LaFratte C   +5 more
europepmc   +1 more source

Issue Information

open access: yes
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 9, September 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy